NEW YORK (GenomeWeb News) – Lipomics Technologies today said that it is collaborating with the Joslin Diabetes Center on two studies, one of which aims to identify biomarkers for potential diagnostics.
 
The first study, on insulin-resistant patients with a family history of type 2 diabetes, aims to identify predictive markers of diabetes that Lipomics could develop into blood-based diagnostics. The second study will focus on the effects of gastric bypass surgery on insulin sensitivity.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.